Conference Report: Psychiatric Genomics Consortium Meeting: Pathways to Drugs, London, March 2017

Héléna A. Gaspar; David A. Collier; Daniel H. Geschwind; Cathryn M. Lewis; Qingqin Li; Bryan L. Roth; Patrick F. Sullivan; Gerome Breen

doi:10.1016/j.biopsych.2018.01.024

Conference Report: Psychiatric Genomics Consortium Meeting: Pathways to Drugs, London, March 2017

Héléna A. Gaspar
, David A. Collier
, Daniel H. Geschwind
, Cathryn M. Lewis
, Qingqin Li
, Bryan L. Roth
, Patrick F. Sullivan
, Gerome Breen

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	e49-e50
Journal	Biological Psychiatry
Volume	84
Issue number	6
DOIs	https://doi.org/10.1016/j.biopsych.2018.01.024
State	Published - 15 Sep 2018
Externally published	Yes

Access to Document

10.1016/j.biopsych.2018.01.024

Cite this

@article{da12591adc184409a13ce51b6ac05afa,

title = "Conference Report: Psychiatric Genomics Consortium Meeting: Pathways to Drugs, London, March 2017",

author = "Gaspar, \{H{\'e}l{\'e}na A.\} and Collier, \{David A.\} and Geschwind, \{Daniel H.\} and Lewis, \{Cathryn M.\} and Qingqin Li and Roth, \{Bryan L.\} and Sullivan, \{Patrick F.\} and Gerome Breen",

note = "Funding Information: DAC reports employment by Eli Lilly and Company, QL reports employment by Janssen Research and Development, and GB acknowledges funding from Eli Lilly and Illumina, Inc. HAG, DHG, CML, PFS, and BLR report no biomedical financial interests or potential conflicts of interest. Funding Information: This work was supported by the United Kingdom National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King{\textquoteright}s College London (to GB, HAG, CML). The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health. ",

year = "2018",

month = sep,

day = "15",

doi = "10.1016/j.biopsych.2018.01.024",

language = "English",

volume = "84",

pages = "e49--e50",

journal = "Biological Psychiatry",

issn = "0006-3223",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Conference Report

T2 - Psychiatric Genomics Consortium Meeting: Pathways to Drugs, London, March 2017

AU - Gaspar, Héléna A.

AU - Collier, David A.

AU - Geschwind, Daniel H.

AU - Lewis, Cathryn M.

AU - Li, Qingqin

AU - Roth, Bryan L.

AU - Sullivan, Patrick F.

AU - Breen, Gerome

N1 - Funding Information: DAC reports employment by Eli Lilly and Company, QL reports employment by Janssen Research and Development, and GB acknowledges funding from Eli Lilly and Illumina, Inc. HAG, DHG, CML, PFS, and BLR report no biomedical financial interests or potential conflicts of interest. Funding Information: This work was supported by the United Kingdom National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King’s College London (to GB, HAG, CML). The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health.

PY - 2018/9/15

Y1 - 2018/9/15

UR - https://www.scopus.com/pages/publications/85051659622

U2 - 10.1016/j.biopsych.2018.01.024

DO - 10.1016/j.biopsych.2018.01.024

M3 - Article

C2 - 29576190

AN - SCOPUS:85051659622

SN - 0006-3223

VL - 84

SP - e49-e50

JO - Biological Psychiatry

JF - Biological Psychiatry

IS - 6

ER -